(0.07%) 5 520.75 points
(0.13%) 39 894 points
(0.16%) 19 782 points
(-0.07%) $81.57
(0.68%) $2.83
(-0.27%) $2 338.10
(0.12%) $29.56
(0.48%) $1 006.60
(0.04%) $0.932
(-0.06%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
-52.38% $ 0.00800
Live Chart Being Loaded With Signals
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors...
Stats | |
---|---|
Dzisiejszy wolumen | 2.48M |
Średni wolumen | 3.98M |
Kapitalizacja rynkowa | 726 089 |
EPS | $-0.110 ( Q2 | 2023-08-10 ) |
Następna data zysków | ( $0 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0182 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00900 (230.77%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-09 | Perkins Adelene Q | Buy | 768 133 | Common Stock |
2023-09-12 | Perkins Adelene Q | Sell | 410 196 | Common Stock |
2023-09-09 | Perkins Adelene Q | Sell | 768 133 | Restricted Stock Unit |
2022-08-02 | Peluso Stephane | Buy | 14 994 | Common Stock |
2022-08-02 | Peluso Stephane | Sell | 50 000 | Restricted Stock Unit |
INSIDER POWER |
---|
-20.55 |
Last 96 transactions |
Buy: 10 433 668 | Sell: 9 549 867 |
Wolumen Korelacja
Infinity Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
CHNA | 0.856 |
10 Najbardziej negatywne korelacje | |
---|---|
HPLT | -0.889 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Infinity Pharmaceuticals Korelacja - Waluta/Towar
Infinity Pharmaceuticals Finanse
Annual | 2022 |
Przychody: | $2.59M |
Zysk brutto: | $1.03M (39.72 %) |
EPS: | $-0.480 |
FY | 2022 |
Przychody: | $2.59M |
Zysk brutto: | $1.03M (39.72 %) |
EPS: | $-0.480 |
FY | 2021 |
Przychody: | $1.86M |
Zysk brutto: | $738 000 (39.72 %) |
EPS: | $-0.530 |
FY | 2020 |
Przychody: | $1.72M |
Zysk brutto: | $682 000 (39.67 %) |
EPS: | $-0.680 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej